Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2009)
Chapter: 2 Current Model for Financing Drug Development: From Concept Through Approval
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
1 Introduction and Overview
Next Chapter: 3 The Food and Drug Administration's Orphan Drug Program
Suggested Citation:
"2 Current Model for Financing Drug Development: From Concept Through Approval." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"2 Current Model for Financing Drug Development: From Concept Through Approval." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"2 Current Model for Financing Drug Development: From Concept Through Approval." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"2 Current Model for Financing Drug Development: From Concept Through Approval." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"2 Current Model for Financing Drug Development: From Concept Through Approval." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.